GitaCloud

Enterprise Transformation

The 90-Day Roadmap That Survives the Boardroom

By Ashutosh Bansal·January 14, 2026

Most transformation roadmaps die in the first board review. The ones that survive share three structural properties — none of which are about the roadmap itself.

Every transformation program starts with a roadmap. Most of them die in the first board review. Not because the roadmap was wrong — most of them are directionally fine — but because the roadmap could not defend itself against a single sharp question.

The question is always the same. It is some version of: what is this worth, and how do you know.

The roadmaps that survive that question share three structural properties. None of them are about the roadmap itself. They are about the diagnostic that produced it.

01The baseline is the enterprise’s own data, not a benchmark.

The fastest way to lose a CFO is to anchor a transformation case on industry benchmarks. Every CFO knows the industry benchmark is wrong for their company. The defensible baseline is the enterprise’s own books, audited by the enterprise’s own finance partner. We have never seen a roadmap survive a board review whose baseline came from a benchmark report.

02The value is dollarized per decision, not per workstream.

The traditional roadmap dollarizes per workstream — “Demand transformation: $40M.” That number is unfalsifiable. It can be doubled or halved with equal credibility. The defensible alternative is to dollarize per decision: this specific decision (inventory policy for the consumer electronics SKU family) is currently leaking this specific amount, and fixing it produces this specific lift. Decisions are the unit. Workstreams are the assembly.

03The sequence is defended, not optimized.

Most roadmaps ship a Gantt chart and call it a sequence. A real sequence defends every adjacency — why this fix comes before that one, what capability is a prerequisite for the next, where the platform decision sits and what has to be true before it can be made. The board does not test the dates. The board tests the logic. The roadmap that has been argued through, internally, against its sharpest critic, is the one that survives.


We run our Roadmap practice on these three rules. The 90-day diagnostic is structured around them, not around a methodology poster. The output is a single document the CEO can hand the board, and the board can defend.

The Gantt chart is the easy part. Everyone has one. The rest is the work.


More from Insights

Talk to a principal about this.

Start the conversation

← All insights